Physiomics Plc (UK) Today
| PYC Stock | 0.80 0.05 6.67% |
Performance7 of 100
| Odds Of DistressOver 75
|
Physiomics Plc is trading at 0.8 as of the 18th of December 2024, a 6.67 percent increase since the beginning of the trading day. The stock's lowest day price was 0.71. Physiomics Plc has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 18th of November 2024 and ending today, the 18th of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Physiomics Plc is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 203.21 M outstanding shares. More on Physiomics Plc
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Physiomics Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Physiomics Plc's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Physiomics Plc or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Chairman | James Millen | ||||
| Thematic Idea | Healthcare (View all Themes) | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Physiomics Plc's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Physiomics Plc's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsPhysiomics Plc can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Physiomics Plc's financial leverage. It provides some insight into what part of Physiomics Plc's total assets is financed by creditors.
| |||||
Physiomics Plc (PYC) is traded on London Exchange in UK and employs 11 people. Physiomics Plc is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.63 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Physiomics Plc's market, we take the total number of its shares issued and multiply it by Physiomics Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Physiomics Plc operates under Biotechnology sector and is part of Health Care industry. The entity has 203.21 M outstanding shares.
Physiomics Plc generates negative cash flow from operations
Check Physiomics Plc Probability Of Bankruptcy
Ownership AllocationPhysiomics Plc owns a total of 203.21 Million outstanding shares. Roughly 97.83 pct. of Physiomics Plc outstanding shares are held by general public with 2.17 % owned by insiders and only 0.0 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Physiomics Ownership Details
Physiomics Plc Risk Profiles
Although Physiomics Plc's alpha and beta are two of the key measurements used to evaluate Physiomics Plc's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.96 | |||
| Semi Deviation | 1.9 | |||
| Standard Deviation | 3.41 | |||
| Variance | 11.61 |
Physiomics Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Physiomics Plc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Physiomics Plc Corporate Management
Elected by the shareholders, the Physiomics Plc's board of directors comprises two types of representatives: Physiomics Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Physiomics. The board's role is to monitor Physiomics Plc's management team and ensure that shareholders' interests are well served. Physiomics Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Physiomics Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Sargent | Chief Officer | Profile | |
| BSc ACA | Head Secretary | Profile | |
| Hayley Close | Head Development | Profile | |
| Venkata Putcha | Head Biostatistics | Profile | |
| Mark Davies | Head Science | Profile |
Other Information on Investing in Physiomics Stock
Physiomics Plc financial ratios help investors to determine whether Physiomics Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Physiomics with respect to the benefits of owning Physiomics Plc security.